Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

Autor: P. B. J. de Sonnaville, J.M. Hazes, P H de Jong, H K Han, Angelique E. A. M. Weel, B van Schaeybroeck, Jolanda J. Luime, Andreas H. Gerards, M V van Krugten, D. Van Zeben, P. A. van der Lubbe, M. Huisman

Publikováno v: Annals of the Rheumatic Diseases, 73(7), 1331-1339. BMJ Publishing Group
Annals of the Rheumatic Diseases

OBJECTIVES: To compare 1-year clinical efficacy of (1) initial triple disease-modifying antirheumatic drug therapy (iTDT) with initial methotrexate (MTX) monotherapy (iMM) and (2) different glucocorticoid (GC) bridging therapies: oral versus a single

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5193473e766876041f5efe57023be5ee
https://doi.org/10.1136/annrheumdis-2013-204788

Simplified versions of the original disease activity score: validation in the BeSt trial

Autor: M. van Oosterhout, M Güler-Yüksel, Pit J S M Kerstens, T.W.J. Huizinga, D. van der Heijde, N.B. Klarenbeek, Cornelia F Allaart, M V van Krugten, R. Koevoets, Ben A. C. Dijkmans

Publikováno v: Annals of the Rheumatic Diseases, 70(8), 1471-1474
Annals of the Rheumatic Diseases, 70(8), 1471-1474. BMJ Publishing Group
Koevoets, R, Klarenbeek, N B, Guler-Yuksel, M, van Oosterhout, M, van Krugten, M V, Kerstens, P J S M, Huizinga, T W J, Dijkmans, B A C, van der Heijde, D M F M & Allaart, C F 2011, ' Simplified versions of the original disease activity score: validation in the BeSt trial ', Annals of the Rheumatic Diseases, vol. 70, no. 8, pp. 1471-1474 . https://doi.org/10.1136/ard.2010.149146

Objective To evaluate three disease activity score (DAS) alternatives without the Ritchie articular index (RAI). To compare the use of patient global assessment (PGA) of disease activity versus global assessment of health (GH) in DAS, DAS alternative

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4fc7944d790b9deb200d9d2dd83d365
https://doi.org/10.1136/ard.2010.149146

TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus

Autor: Ferdinand C. Breedveld, Cornelis L. Verweij, R. R. P. de Vries, Twj Huizinga, M V van Krugten, V. Keijsers, R. G. J. Westendorp, MW van der Linden, G. M. T. Schreuder, M. J. Rood, Willem Verduyn, E. Zanelli

Publikováno v: Arthritis & Rheumatism. 43:129-134

Objective To evaluate the respective contributions of tumor necrosis factor (TNF) promoter polymorphisms and HLA–DR alleles to susceptibility to systemic lupus erythematosus (SLE). Methods TNF-238G/A and 308G/A promoter polymorphisms and HLA–DRB1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::400aef4fad27e39b575ee8506e83a378
https://doi.org/10.1002/1529-0131(200001)43:1<129::aid-anr16>3.0.co

FRI0087 Predictors for Attaining Remission at Two Consecutive Visits in Newly Diagnosed Early RA Patients

Autor: M. Hazes, Andreas H. Gerards, Angelique E. A. M. Weel, M. Kuijper, P. de Jong, J. van Zeben, B. Grillet, Jolanda J. Luime, P. B. J. de Sonnaville, M V van Krugten, Ilja Tchetverikov

Publikováno v: Annals of the Rheumatic Diseases. 75:458.2-459

Background Early and intensive treatment with DMARDs are essential for remission induction in newly diagnosed RA patients. However, demographic, psychosocial and disease related factors may play a role as well. Objectives To investigate which demogra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7eb3142856d4fdf1af1a1f78eb447f75
https://doi.org/10.1136/annrheumdis-2016-eular.3946

Treatment with TNF-alpha inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis

Autor: M Güler-Yüksel, B A C Dijkmans, D. van Schaardenburg, J.K. de Vries-Bouwstra, Twj Huizinga, Iain Watt, W.F. Lems, M V van Krugten, Margreet Kloppenburg, Yvonne P M Goekoop-Ruiterman, Cornelia F Allaart

Publikováno v: Guler-Yuksel, M, Allaart, C F, Watt, I, Goekoop-Ruiterman, Y P, Bouwstra, J K, van Schaardenburg, D, van Krugten, M V, Dijkmans, B A C, Huizinga, T W, Lems, W F & Kloppenburg, M 2010, ' Treatment with TNF-alpha inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis ', Osteoarthritis and Cartilage, vol. 18, no. 10, pp. 1256-1262 . https://doi.org/10.1016/j.joca.2010.07.011
Osteoarthritis and Cartilage, 18(10), 1256-62
Osteoarthritis and Cartilage, 18(10), 1256-1262
Osteoarthritis and Cartilage, 18(10), 1256-1262. W.B. Saunders Ltd

Objectives: To investigate the association between systemic and local inflammation and incident and progressive radiographic secondary osteoarthritis (OA) in interphalangeal joints (IPJs) over 3 years in rheumatoid arthritis (RA) patients and the eff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9965302f4ce79d49cc9cc084a81fb661
https://research.vumc.nl/en/publications/f042c4b4-b1c7-4a80-b475-2fff578d8f44